Barclays »

Tevogen Bio Hldgs shares owned by Barclays

Quarter-by-quarter ownership of Tevogen Bio Hldgs (TVGN) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Tevogen Bio Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Tevogen Bio Hldgs held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tevogen Bio Hldgs by Barclays

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.0k 7.5k 0.66

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Fund (IWM)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Tesla Opt Call Option (TSLA)
Ishares Tr Fund (HYG)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)
Texas Instruments Incorporated (TXN)
Alphabet Inc Class C cs (GOOG)

View all positions for Barclays

Top funds holding Tevogen Bio Hldgs

Polar Securities
Portland Global Advisors
Cantor Fitzgerald, L. P.
Geode Capital Management
BlackRock
New York State Common Retirement Fund
Vanguard Group
State Street Corporation
Charles Schwab Investment Management
Citadel Advisors
Alpine Partners VI
Morgan Stanley
Rhumbline Advisers
Two Sigma Securities
Bank of America Corporation

View all funds holding Tevogen Bio Hldgs